Skip to main content

Navigation group

534,046 articles related to "Chemical Defense"

Articles

Original Research

Published on 29 Jul 2024

Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice

in Experimental Pharmacology and Drug Discovery

  • Kirill V. Odarenko
  • Aleksandra V. Sen’kova
  • Oksana V. Salomatina
  • Oleg V. Markov
  • Nariman F. Salakhutdinov
  • Marina A. Zenkova
  • Andrey V. Markov
Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1428924

Clinical Trial

Published on 29 Jul 2024

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

in Vaccines and Molecular Therapeutics

  • Mostafa Ghanei
  • Babak Ghalebaghi
  • Ramin Sami
  • Mehdi Torabizadeh
  • Majid Mirsadraee
  • Babak Amra
  • Marzieh Tavakol
  • Hanieh Raji
  • Morteza Fallahpour
  • Arda Kiani
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial
Frontiers in Immunology
doi 10.3389/fimmu.2024.1425906
  • 292 views